ARMN's $240M cash and healthy cash flows fuel growth initiatives as shares soar nearly 97% YTD on gold price momentum.

An application has been made to the Financial Conduct Authority (‘FCA’) and the London Stock Exchange (‘LSE’) for 21,772 ordinary shares of £0 ...

Nu Holdings Ltd. remains a long-term buy, but recent gains have compressed the margin of safety, warranting a more cautious ...

Iterum Therapeutics plc (Nasdaq: ITRM) ("Iterum" or the "Company"), a company committed to delivering next generation oral and IV antibiotics to ...

Aris Mining Corporation ARMN is making notable strides in its key development projects that would underpin its future production upside. ARMN is advancing its expansion projects, including the Segovia ...

6 June 2025 N4 Pharma plc ("N4 Pharma" or the "Company") Final Results Posting of Annual Report and Notice of AGM N4 Pharma plc (AIM: N4P), the UK biotech developing Nuvec®, its proprietary gene ...

DUBLIN and CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM ... includes senior commercial leadership roles at Paratek Pharmaceuticals, BTG Pharmaceuticals, Auxilium, ...

Get the detailed quarterly/annual income statement for Banco BTG Pactual S.A. (BPAC3.SA). Find out the revenue, expenses and profit or loss over the last fiscal year.

Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities Bytes Technology Group plc (Incorporated in England and Wales) (Registered number: 12935776) LEI: ...